Concerning Antibiotic Resistance
Antibiotic resistance occurs when microorganisms, such as bacteria and fungi acquire the ability to withstand the medications intended to kill them. This indicates that the germs are not eliminated and continue to multiply.
There are over 2,8 million antibiotic-resistant illnesses in the United States each year. According to the 2019 Antibiotic Resistance (AR) Threats Report from the CDC, over 35,000 people die. When Clostridioides difficile, a non-resistance bacterium that can cause fatal diarrhea and is related to antibiotic usage, is added, the total number of illnesses and fatalities in the United States approaches 3 million and 48,000, respectively.
Antibiotic resistance has the potential to impact individuals of all ages and the healthcare, veterinary, and agricultural businesses. This makes it one of the most critical public health issues globally.
To be hazardous, bacteria and fungi need not be resistant to every antibiotic. However, even resistance to a single antibiotic can have severe consequences. For instance:
Infections resistant to antibiotics and need second-and third-line treatments can harm patients by producing severe adverse effects, such as organ failure, and prolonging care and recovery by several months.
Numerous medical achievements, including joint replacements, organ transplants, cancer therapy, and the management of chronic disorders such as diabetes, asthma, and rheumatoid arthritis, rely on the capacity to combat infections with antibiotics.
In certain instances, these infections are incurable.
If antibiotics lose their efficacy, we will no longer be able to treat infections and control these hazards to public health.